The DEBATE Study "DEvelopment of Endotype-based Biomarkers for the Monitoring of Greek pATiEnts With CRSwNP"
NCT07663409 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 230
Last updated 2026-07-22
Summary
Given the high variability in the inflammatory profiles of CRSwNP (Chronic rhinosinusitis with nasal polyps) patients that influence both disease phenotype and response to treatment, exploring further potential targets is crucial for advancing novel biologic treatment strategies. By indicating the efficacy of targeted therapy, as well as determining clinical features, endotyping of CRSwNP may offer a useful tool to better tailor treatment approaches in this heterogenous patient population. This study is the first national effort to collect data on inflammatory markers and burden of CRSwNP patients in Greece aiming at identifying disease endotypes based on patients' inflammatory profile.
Conditions
- CRSwNP or CRSsNP Patients
Interventions
- OTHER
-
Not applicable - NIS study
Not applicable - NIS study
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-29
- Primary Completion
- 2029-12-31
- Completion
- 2029-12-31
Countries
- Greece
Study Locations
More Related Trials
-
Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis
NCT06372678 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study in Male and Female Adult Participants With Chronic Rhinosinusitis With Nasal Polyps In the Greater Gulf Region
NCT05649813 ·Status: COMPLETED
-
Effectiveness on Sino-Nasal Symptoms Of Mepolizumab 300
NCT07592104 ·Status: COMPLETED
-
Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma
NCT06069310 ·Status: ACTIVE_NOT_RECRUITING
-
Predictive Factors in Chronic Rhinosinusitis With Nasal Polyps
NCT06459622 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps
NCT06516302 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis
NCT07420257 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Preoperative Stapokibart for Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps
NCT07616609 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps
NCT06801353 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps
NCT05131464 ·Status: COMPLETED ·Phase: PHASE2
-
Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab in France
NCT06393946 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma
NCT07436949 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Dupilumab in Chinese Adult Participants With CRSwNP
NCT05878093 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps
NCT05324137 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Biologics in Chronic Rhinosinusitis With Nasal Polyposis
NCT06824649 ·Status: RECRUITING ·Phase: PHASE4
-
Early-onset Dupilumab Effects in CRSwNP
NCT06188871 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Adult Japanese Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
NCT07484230 ·Status: WITHDRAWN ·Phase: PHASE3
-
Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment
NCT05642806 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps
NCT05274750 ·Status: COMPLETED ·Phase: PHASE3
-
Inflammatory Profiles, Histopathological Features, and Remodeling Factors in Chronic Rhinosinusitis With Nasal Polyps
NCT07528820 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Dupilumab in CRSsNP
NCT04678856 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients
NCT07446738 ·Status: RECRUITING
-
Dupilumab in the Treatment of Severe Uncontrolled CRSwNP: a Multicentre Observational Real-life Study (DUPIREAL)
NCT05529784 ·Status: UNKNOWN
-
An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps
NCT03478930 ·Status: COMPLETED ·Phase: PHASE3
-
The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps
NCT05873803 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2